Drug Shortage Report for IPRAVENT
Report ID | 85654 |
Drug Identification Number | 02246084 |
Brand name | IPRAVENT |
Common or Proper name | Ipravent |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 0.06% |
Dosage form(s) | SOLUTION |
Route of administration | NASAL |
Packaging size | 15ML |
ATC code | R01AX |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-05 |
Estimated end date | 2019-07-19 |
Actual end date | 2019-07-18 |
Shortage status | Resolved |
Updated date | 2019-08-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-08-22 | French | Compare |
v6 | 2019-08-22 | English | Compare |
v5 | 2019-07-04 | French | Compare |
v4 | 2019-07-04 | English | Compare |
v3 | 2019-06-06 | English | Compare |
v2 | 2019-06-05 | French | Compare |
v1 | 2019-06-05 | English | Compare |
Showing 1 to 7 of 7